The Latest in
Mental health care for the modern world
Over 80% of patients treated with Transcranial Magnetic Stimulation (TMS) experience sustained positive improvements in their overall condition and over 50% enjoy full remission.
Up to 73% of patients suffering with Major Depressive Disorders (MDD), including suicidal ideation, experienced a sustained improvement after the administration of Ketamine IV treatments.
When used alongside another antidepressant, over 70% of SPROVATO® recipients experience at least a 50% improvement in symptoms of Major Depressive Disorder (MDD)
FDA Approved & Covered by Insurance
Medicare & Tricare